Is Mineralys Therapeutics, Inc. (MLYS) a Buy, Sell, or Hold?
NASDAQ : MLYS
Mineralys Therapeutics, Inc. — Analyst Ratings
$27.21 USD
$0.5 (1.87%)
- Volume
- 811.11K
- Average Volume
- 1.49M
- Market Capitalization
- $2.4B
- P/E Ratio
- -13.27
- Dividend Yield
- 0.00%
- Price Target
- $43.00
- Year High
- $47.65
- Year Low
- $12.59
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $44.33
Analyst Consensus Summary
Consensus Rating
Strong Sell
8 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-36.7%
vs Current Price
Price Target
$43.00
Average TargetPrice Target Range
Lowest Target
$30.00
-9.3% DOWNSIDE
Average Target
$43.00
Median Estimate
Highest Target
$56.00
-51.4% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 8
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 7 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Jefferies | Dennis Ding | $30 | $26.23 | 2026-03-13 12:40 PM | 14.4% |
| H.C. Wainwright | Matthew Caufield | $56 | $27.23 | 2026-03-10 06:12 AM | 105.7% |
| Guggenheim | Seamus Fernandez | $48 | $15.11 | 2025-05-14 08:07 AM | 217.7% |
| H.C. Wainwright | Matthew Caufield | $42 | $14 | 2025-04-02 06:13 AM | 200.0% |
| Goldman Sachs | Richard Law | $30 | $13.03 | 2024-04-01 11:18 PM | 130.2% |